Target identification for repurposed drugs active against SARS-CoV-2 via high-throughput inverse docking (version 1)
Screening already approved drugs for activity against a novel pathogen can be an important part of global rapid-response strategies in pandemics. Such high-throughput repurposing screens have already identified several existing drugs with potential to combat SARS-CoV-2. However, moving these hits fo...
Guardado en:
| Autores principales: | Ribone, Sergio P., Paz, S. Alexis, Abrams, Cameron F., Villarreal, Marcos A. |
|---|---|
| Formato: | Preimpreso |
| Lenguaje: | Español |
| Publicado: |
Cambridge University Press. ChemRxiv
2021
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/11086/20029 https://chemrxiv.org/engage/chemrxiv/article-details/60d4e352e211334430e0a008 |
| Aporte de: |
Ejemplares similares
-
Reposicionamiento de fármacos para SARS-CoV-2: nuevos usos para drogas ya aprobadas - COVID 19
por: Cavasotto, Claudio, et al.
Publicado: (2021) -
Dock Sud : un sentimiento
por: Pikulski, María Teresa
Publicado: (1991) -
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
por: Prada Gori, Denis Nihuel, et al.
Publicado: (2023) -
Identification of renin inhibitors peptides from amaranth proteins by docking protocols
por: Nardo, Agustina Estefanía, et al.
Publicado: (2020) -
Small molecule stabilization of non-native protein-protein interactions of SARS-CoV-2 N protein as a mechanism of action against COVID-19
por: Fernández, Julián, et al.
Publicado: (2020)